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Cell cycle is maintained almost all the times and is controlled by various regulatory proteins and their complexes (Cdk+Cyclin) in 
different phases of interphase (G1, S and G2) and mitosis of cell cycle. A number of mechanisms have been proposed for the 
initiation and progression of carcinogenesis by abruption in cell cycle process. One of the important features of 
cancer/carcinogenesis is functional loss of these cell cycle regulatory proteins particularly in CDKs and cyclins. We hypothesize 
that there is a direct involvement of these cell cycle regulatory proteins not only at the genetic level but also proteins level, during 
the initiation of carcinogenesis. Therefore, it becomes significant to determine inconsistency in the functioning of regulatory 
proteins due to interaction with carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Hence, we investigated the 
interaction efficiency of NNK, against cell cycle regulatory proteins. We found a different value of ∆G (free energy of binding) 
among the studied proteins ranging between -3.29 to -7.25 kcal/mol was observed. To validate the results, we considered Human 
Oxy-Hemoglobin at 1.25 Å Resolution, [PDB_ID:1HHO] as a +ve control, (binding energy -6.06 kcal/mol). Finally, the CDK8 
(PDB_ID:3RGF) and CDK2 (PDB_ID:3DDP) regulatory proteins showing significantly strong molecular interaction with NNK -7.25 
kcal/mol, -6.19 kcal/mol respectively were analyzed in details. In this study we predicted that CDK8 protein fails to form functional 
complex with its complementary partner cyclin C in presence of NNK. Consequently, inconsistency of functioning in regulatory 
proteins might lead to the abruption in cell cycle progression; contribute to the loss of cell cycle control and subsequently 
increasing the possibility of carcinogenesis. 
 
 





Cell cycle is controlled by various regulatory proteins (check 
points) for proper cell division. Infact, cell division of cell is 
divided into two stages: mitosis (M) and interphase (I) 
including G1, S and G2 transition phases [1]. The transition 
from one phase to another phase occurs in an orderly fashion 
and is regulated by different type of cellular proteins, 
particularly cyclin-dependent kinases (CDKs-family of 
serine/threonine protein kinases) and cyclins are 
activated/deactivated at specific points. Therefore, CDKs 
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induce downstream processes by phosphorylating the 
regulatory proteins in cell cycle [2]. However, different types of 
cyclins D (cyclin D1, cyclin D2 and cyclin D3) are essential for 
the regulation of cell cycle. Further, cyclins bind to CDKs and 
form CDK-cyclin complex. This complex/s is/are very 
important for phase progression in cell cycle [3]. The functional 
activity of that CDK-cyclin complex is induced conformational 
changes due to phosphorylation in conserved threonine and 
tyrosine residues of CDKs part. Thus the complex (Cdk+Cyclin) 
enhances or suppresses the binding efficiency of their specific 
cyclin partner [4]. In case of cancer, mutations have been 
observed in genes encoding CDKs, Cyclins (D1, D2, D3, A, H, T 
& C), CDK-activating enzymes (CAK), CKI and CDK-substrates 
[5]. Consequently, changes in functioning of CDKs activity to 
formed Cdk+Cyclin complex, an important part of many 
cancers, as well as other disease states, generally through 
elevated and/or inappropriate activation [6]. One of the 
probable ways of loss of cell cycle control could be disruption 
of these regulatory proteins CDKs (check points) by a direct 
interaction with chemical/carcinogen. In the present study, we 
investigated the possible molecular interactions between CDKs, 
cyclins with potent cigarette smoke carcinogen 4-
(Methylnitrosamino)-1-(3-Pyridyl)-1-butanone (NNK).   
  
NNK is a yellow crystalline compound with a molecular 
formula C10H13N3O2, (Mol Weight = 207.2316) derived from 
tobacco alkaloids (nitrosamine) as a potent carcinogen [7]. The 
concentrations of NNK in tobacco substances such as 1-20 
μg/g, 20-310 ng/cigarette and ≤26 ng/m3 in snuff, cigarette 
mainstream smoke, and in indoor air respectively [8]. The 
existences of substantial amount of NNK in tobacco products 
play a very significant role as a main cause of cancer in 
population [9]. Ultimately, NNK is considered as a major 
contributor as well as risk factor to lung carcinogenesis [10-11]. 
NNK and its metabolite NNAL, has already been reported to 
molecular interaction with DNA repair proteins primarily by 
our group [12].  
 
We analyzed the molecular interaction, based on binding 
efficiency of potent carcinogen NNK against CDKs (check 
points) and cyclins involved in the cell cycle process. In case of 
cancer, cells develop an autonomous set of instructions against 
normal rules, leading to uncontrolled, undifferentiated growth 
and proliferation called an abnormal condition of a cell known 
as carcinogenicity. The carcinogen NNK and its metabolite 
NNAL directly bind with DNA repair proteins to make DNA 
adduct. Therefore, possibility exists that NNK may directly 
interact with these regulatory protein (CDKs, cyclin) and affect 
the functional activity of CDK-cyclin complex in cell cycle 
regulation. The carcinogen NNK induced cell cycle abruption 
may in turn result in hastened DNA replication, with a 
compromised proofreading by DNA pol/RNA pol.   This 
process in a whole may give rise to daughter cell with loads of 
mutations in their DNA. Therefore we designed this study to 
investigate and determine whether the carcinogen NNK, apart 
from directly causing damage to regulatory proteins, is also 
capable of affecting their functionalities in term of binding 
efficiency of CDKs to their specific cyclins partner (A, C, D, D1, 




Preparation of receptor- protein structures 
The 3D structures of check point proteins (CDKs & Cyclins) 
involved in cell cycle regulation were obtained from PDB 
(Protein Data Bank) and some other proteins retrieved from 
MODBASE server Table 1 (see supplementary material). 
MODBASE is a queryable database of annotated protein 
structures models, theoretically calculated models, which may 
contain significant errors, not experimentally determined 
structures [13]. Published protein structures were edited, to 
remove HETATM by using Discovery Studio Visualizer 
(Version 2.5.5). And Chimera was used for energy 
minimization, removal of steric collision (forces) with the 
steepest descent steps 1000, steepest descent size 0.02 Å, 
conjugated gradient steps 1000 and gradient step size 0.02 Å for 
the conjugate gradient minimization [14-15]. Protein structure 
visualization and image generation were performed using 
PyMOL software (DeLano Scientific, Palo Alto, CA). 
 
 
Figure 1: (A) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-
butanonePubChem Compound ID- 47289,ChemSpider ID-
43038; (B) 3RGF:CDK8 interact with carcinogen NNK; (C) 
3DDP:CDK2 interact with carcinogen NNK 
 
Preparation of ligand structure 
Potent cigarette smoke carcinogen NNK (4-
(Methylnitrosamino)-1-(3-pyridyl)-1- butanone) ligand file was 
retrieved in (dot).mol format Table 2 (see supplementary 
material) (Figure 1) from latest version of Chem Spider 
Chemical Database. This file format could not directly use by 
Autodock (4.0) tool [16]. Thus that file was finally converted it 
into.(dot)pdb file format using DS Visualizer (version 2.5.5), so 
it easier to comprehend chemoinformatics and molecular 
mechanics of ligand and different receptor proteins interacting 
molecules. Further, ligand was submitted for minimization by 
using Chimera (version 1.5.3) with Genetic Algorithm Steps 
2000 and 0.5 grid units Optimized [17]. 
 
In silico Studies 
In silico studies were performed by Autodock version 4.0 suit 
with Cygwin interface tool [18-19]. We selected molecular 
docking methods for CDKs and NNK interaction, followed by 
retrieving the best conformations of check point (CDKs) as 
regulatory proteins and carcinogen (NNK), on the basis of 
binding energy value (kcal/mol). First of all, we marked all 
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water molecules (H2O) in proteins then removed from targeted 
protein structure, before apply docking performance. Then only 
hydrogen atoms were added to all target proteins. After that 
Kollman united charges and salvation parameters were applied 
to selected regulatory proteins (CDKs and cyclins). Gasteiger 
charge also was charged to ligand (NNK). Then defined Grid 
box was set to cover the maximum part (including target site) 
of selected protein for ligand interaction. The value was set to 
standard 60×60×60 Å in X, Y and Z coordinate of grid point 
with default value of grid points spacing 0.375 Å. Lamarckian 
Genetic Algorithm (LGA) was applied for receptor protein and 
ligand for flexible docking calculations [20]. The LGA 
parameters like population size (ga_pop_size), energy 
evaluations (ga_num_generation), mutation rate, crossover rate 
and step size were set to 150, 2500000, 27000, 0.02, 0.8 and 0.2 Å, 
respectively. The LGA runs were set to as standard 50 runs. We 
observed all 50 conformations of selected proteins with ligand 
complex were analyzed for the interaction orientations 
including binding energy of the docked structure using 
Discovery Studio Visualizer version 2.5.5. 
 
Protein-Protein Interaction analysis 
The interacting regulatory proteins (CDKs) and cyclins were 
found using STRING 9.0 database that predict, interacting 
proteins against your query. We found interface residues in 
CDKs & Cyclins using PDBe PISA, an interactive tool for the 
exploration of macromolecular (protein, DNA/RNA and 
ligand) interfaces [21]. The Discovery studio 2.5 was used for 
Zdock (Dock Proteins) and Zdock score obtained from Protein-
Protein interactions (Cdk+Cyclin) as well as from Protein-
Complex (NNK+CDK & Cyclin) interaction. 
 
Z dock calculations 
Zdock is one of the successful suites that have shown great 
prediction abilities in Critical Assessment of Predicted 
Interactions (CAPRI) [22]. Zdock uses a fast Fourier transform 
to search all possible binding modes for the proteins, 
evaluating based on shape, desolvation energy, and 
electrostatics. The top 2000 predictions from Zdock where they 
are minimized by CHARMM with create fixed atom constraint 
in backbone of protein and again create Harmonic restraint in 
selected protein for improving the energies and eliminate 
clashes. ZDOCK is an initial stage rigid body molecular 
docking algorithm that uses a fast Fourier transform (FFT) 
algorithm to improve performance for searching in 
translational [23]. All of the available structures from NMR 
were used to calculate docking poses and the structures 
obtained were subjected to energy minimization using, smart 
minimize algorithm (Max steps 200, RMS gradient 0.01) in the 
program D.S. 2.5. The resulting highest values of score were 
used as appropriate conformational pose with Zdock score 
value Table 3 (see supplementary material). 
 
Results: 
The ligand structure NNK (4-(Methylnitrosamino)-1-(3-
Pyridyl)-1-butanone) as a potent cigarette smoke carcinogen 
described in this study was retrieved from latest version of 
Chem Spider Chemical Database in (dot).mol format (Table 2 
& Figure 1A) with PDB-ID: 1B17. The structures of the cell 
cycle regulatory proteins CDKs (CDK8:3RGF, CDK2:3DDP, 
CDK7:1UA2, CDK6:1BLX, CDK9:3BLH & CDK4:3G33) 
obtained from PDB and other complementary partner protein 
cyclin (cyclin A: 1JSU, cyclin H: 1KXU, cyclin D3: 3G33, cyclin 
D: 2W9F, cyclin C: 1ZP2 and cyclin T: 3BLR) were retrieved 
from MODBASE server. Table 1 & Table 4 (see supplementary 
material) show the docked score (binding energy) of ligand 
NNK against cyclin dependents kinases (CDKs), 
complementary partner proteins cyclins. While Figure 1 B & C 
were indicated the docking images with best molecular 
interaction orientation. In this in silico study, the docking scores 
(binding energy) of CDK8 and CDK2 regulatory proteins 
against the carcinogen NNK, -7.25 kcal/mol & -6.19 Kcal/mol 
respectively were more than that of positive control Human oxy-
hemoglobin binding energy -6.06 kcal/mol. The residues ARG 150, 
ASP 151, LEU 152, LYS 153, THR 196, PHE 197, TRP 198, TYR 
199, ARG 200, ALA 201, LEU 204, TYR 211, ILE 215 and ALA 
219 of CDK8 and ILE 10, VAL 18, ALA 31, LYS 33, VAL 64, PHE 
80, GLU 81, PHE 82, LEU 83, HIS 84, GLN 85, ASP 86, LEU 134 
and ALA 144 of CDK2 actively participate in molecular 
interaction with NNK as shown in Table 5 (see supplementary 
material). The residues ARG, ASP, LEU, LYS, TYR, VAL and 
ALA from all regulatory proteins (CDKs) commonly interacted 
with carcinogen NNK through hydrogen bonds. The functional 
integrity with interaction efficiency of CDKs once bound to 
NNK was also evaluated by using Zdock method. We obtained 
Zdock-scores of CDK8 with its corresponding partner cyclin C 
was 30.12, and of CDK2 with its corresponding partner cyclin A 
was 21.62. Whereas, the complex CDK8+NNK when docked 
with its partner cyclin C showed Zdock score 19.12, and 
CDK2+NNK when docked with its partner cyclin A showed 
Zdock score 21.34. Reduction in the Zdock score of CDK8 after 
it forms complex with NNK may represent a loss in its capacity 
to bind with partner cyclin C, once bound with NNK. Whereas, 
regulatory protein CDK2 doesn’t show significant change in 
Zdock value, after binding with NNK as shown in (Table 3). 
 
Discussion: 
An insilico approaches were applied to evaluate protein-ligand 
and protein-protein interaction (PPI) for identifying possible 
targets of carcinogen (NNK) amongst cyclin dependent-kinases 
(CDKs) as well as with their respective partner cyclins. In order 
to gather in-depth knowledge on, an important issue that how 
the cigarette smoke carcinogen NNK interfere the mechanism 
of signals through CDK complex (Cdks+Cyclins) in 
proliferation, cell division and in abruption of cell cycle. In this 
study, we characterized and identified the molecular 
interaction of NNK with all  regulatory proteins (CDK2, CDK4, 
CDK6, CDK7, CDK8, and CDK9) and with their respective  
partner cyclins (Cyclin A, Cyclin E, Cyclin D, D1, D2, D3, 
Cyclin C, Cyclin H, and Cyclin T) by using Autodock and 
Zdock (protein-protein interaction) methods. To validate our in 
silico study, we considered Human oxy-hemoglobin at 1.25 Å 
resolution, [PDB ID-1HHO] as a +ve control, which showed 
binding energy of -6.06 kcal/mol, as the binding of Human oxy-
hemoglobin with NNK has previously been quantified in 
tobacco users and is considered as a biochemical marker for 
uptake of tobacco specific nitrosamines [24]. The docking 
outputs indicated that potent cigarette smoke carcinogen NNK 
shows the binding efficiency (∆G) against cell cycle regulatory 
enzymes/proteins (CDKs) ranging, -3.95 to -7.25 kcal /mol 
(Table 1). Simulations depicted that two regulatory proteins 
CDK8 (3RGF) & CDK2 (3DDP) showed better potential to bind 
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carcinogen NNK as compared to +ve control, i.e. -7.25 & -6.19 
Kcal/Mol (Figure 1 B & C) respectively. During the protein-
ligand interaction, the amino acid residues of CDK8 involved in 
interaction with ligand (NNK) were identified as ARG150, 
ASP151, LEU152, LYS153, THR196, PHE197, TRP198, TYR199, 
ARG200, ALA201, LEU204, TYR211, ILE215, and ALA219. 
While, in case of protein CDK2 the amino acid residues, namely 
ILE10, VAL18, ALA31, LYS33, VAL64, PHE80, GLU81, PHE82, 
LEU83, HIS84, GLN85, ASP86, LEU134, and ALA144 were 
found to be involved efficiently in the interaction with ligand 
NNK. In fact, amino acid residues, particularly ARG, ASP, 
LEU, LYS, TYR, VAL and ALA of both CDK8 and CDK2 were 
found to be essential for the interaction of carcinogen NNK 
(Table 5). This molecular interaction between CDKs and NNK 
is validated on the basis of their binding energy (∆G) obtained 
from best docked conformations. It has been reported that 
Cyclin Dependent Kinase-8 is actively involved in the regulation 
of mRNA transcription and considered as a potent oncogene in 
colon carcinogenesis. In addition, mutated or amplified CDK8 
with increased expression is a common observation during a 
variety of human cancers [25]. However, we further explored 
the interaction impact of NNK on CDK8 (3RGF) in term of 
binding efficiency towards its respective partner cyclin C. For 
this purpose, we applied an in silico Zdock method for 
calculating Zdock score of protein-protein interaction (PPI) 
between CDK8 Vs Cyclin C complex and further compared it 
with protein complex interaction (CDK8+NNK Vs Cyclin C) by 
using Discovery studio 2.5. Results clearly depicted that 
significant loss of binding energy of CDK8 Vs Cyclin C from 
30.12 (PPI) to 19.12 for NNK bound with CDK 8 complex Vs 
Cyclin C (PCI) at coordinates X -17.585, Y 11.939 & Z 17.689. 
These results predicted that binding of NNK at the active site of 
CDK8 strongly interferes with the natural binding of cyclin C to 
the active site of CDK8, rendering it unable to form functional 
complex (CDK8+cyclin C). It has been reported that CDK8 
positively regulates transcription, by directly phosphorylating 
p53 and histone H3, or by facilitating assembly of Pol II 
elongation complex [26]. The CDK8-cyclin C complex is the 
part of RNA Polymerase II, which regulate the transcription of 
general transcription initiation factor IIH (TFIIH), controlling 
the basal transcription machinery. Failing the formation of 
CDK8-cyclin C complex may eventually will result in failure of 
the transcriptional regulation of a member of RNA-Pol-II 
dependent genes [27]. CDK8 plays significant role in regulating 
cell cycle progression [28] And CDK 8-cyclin C complex 
abnormality has many times reported to result in 
tumorogenesis [29]. When we performed same Zdock study 
with other protein CDK2, it was observed that NNK binding 
with the CDK2 didn’t significantly interfere natural binding of 
its partner cyclin A Table 3. Previously QMS Jamal, et al., 2012 
presented Zdock based analysis to determine the 
loss/incapability in formation of functional complex of 
regulatory proteins in DNA repair pathways after its binding 
with a concerned chemical/carcinogen [12]. The binding of 
NNK with CDK8 therefore, may be an important event in 
carcinogenesis caused by cigarette smoke carcinogen and 
should be studied in depth. 
 
Conclusion: 
In silico study explores the interaction of CDK8 (cyclin 
dependent kinase-8) with NNK, a widely inhaled potent 
cigarette smoke carcinogen among the young generation of 
population. CDK8, cyclin C and its complex (CDK8+cyclin C) 
are the key mediator of cell cycle progression which play a vital 
role in cell cycle perturbation due to potential interaction of 
cigarette smoke carcinogen NNK. The hydrogen bonds and 
certain amino acid residues ARG, ASP, LEU, LYS, TYR, VAL 
and ALA play a key role in the correct positioning of CDKs 
within the active site of NNK to permit docking interaction. 
The effect of molecular interaction of NNK on the binding with 
CDKs is elucidated. Study indicated the loss of functional 
complex of these enzymes/regulatory proteins (Cdk+Cyclin), 
which probably could be a reason for perturbation in cell cycle 
process resulting in occupied active site of CDKs by NNK. 
Furthermore, our study suggests that carcinogens (NNK) 
positively alter the mechanisms of cell cycle progression 
pathways and enzymes functioning could be affected by 
carcinogens. Computer based structural analysis of bio 
macromolecules and their molecular interactions (ligand and 
protein) could play an important role in assessment of risk to a 
number of diseases including cancer. At last but not least, a 
deep analysis is needed to elucidate the perturbation of cell 
cycle mechanisms with best suitable techniques and tools. In 
vivo and In vitro validation is needed to authenticate insilico 
results obtained from this study.  
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Table 1: Cyclin Dependent Kinases (Cdks) docked with carcinogen NNK, results obtained by Autodock 4.0 







1 3RGF CDK8 -7.25 4.84 24.50 
2 3DDP CDK2 -6.19 28.79 34.47 
3 1UA2 CDK7 -6.02 38.41 34.41 
4 1BLX CDK6 -5.68 68.61 73.14 
5 3BLH CDK9 -4.29 711.60 56.20 
6 3G33 CDK4 -3.95 128.00 71.85 
*rmsd: root mean square deviation 
 
Table 2: Fact of Potent Carcinogen NNK 
 Carcinogen IUPAC Name Mol. Formula Mol. Weight Smiles 
 NNK 4-(Methylnitrosamino)-1-(3-pyridyl)-1-
butanone 
C10H13N3O2 207.22912 g/mol CN(CCCC(=O)C1=CN=CC=C1)N
=O 
 
Table 3: Protein–Protein Interaction of Cyclin Dependent-Kinases (CDKs) and their Respective Regulatory Proteins (Cyclins) 
S. N. PDB _Id Name of Proteins Name of Regulatory 
Proteins 
Coordinates of Docked  Pose 




* Zdock Score 
1 3RGF CDK8 Cyclin C -17.585, 11.939 & 17.689 30.12 19.12 
2 3DDP CDK2 Cyclin A   13.731, 29.461 &  8.810  21. 62  21.34 
*Complex contain NNK+CDKs Vs Cyclins 
 
Table 3 4: Regulatory Proteins (Cyclins) Docked with Carcinogen NNK, Results Obtain By Autodock 4.0 
S.N. Pdb_Id Name of Proteins Binding Energies (Kcal/Mol) Estimated Inhibition Constant (µm) Reference r.m.s.d. 
1 1JSU Cyclin A -6.00 40.24 55.67 
2 1KXU Cyclin H -5.68 68.93 93.16 
3 3G33   Cyclin D3 -5.35 119.87 67.33 
4 2W9F Cyclin D -4.98 222.64 88.45 
5 1ZP2 Cyclin C -4.85 285.63 98.37 
6 3BLR Cyclin T -3.29 3880.0 39.84 
 
Table 5: Interacting Amino Acid Residues Involved in Complexes formation with NNK in Cell Cycle Regulatory Proteins 





Residues Involved In  
Hydrogen Bonding 
Amino Acid Residues  
Involved In Interaction 
With NNK Carcinogen 
Common Interacting A. 
A. Residues In 
Regulatory Proteins 
1 3RGF CDK8 6 TYR 199: N- - -PHE 
197: O 
TRP 198: N- - -O 15: 
NNK 
TYR 199: N- - -N 14: 
NNK 
TYR 199: N- - -O 15: 
NNK 
ALA 201: N- - -N 10: 
NNK 
TYR 211: OH- - -O 7: 
NNK 
ARG 150, ASP 151, LEU 
152, LYS 153, THR 196, 
PHE 197, TRP 198, TYR 
199, ARG 200, ALA 201, 

















ARG,    ASP,  LEU, LYS, 




2 1BLX CDK6 7 ARG 144: HN- - 
OD1:ASP201 
LEU 146: HN - -O15: 
NNK 




TYR 185, ARG 186, ALA 
187, VAL 190, TYR 196, 
VAL 200, ASP 201, SER 
204.  
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SER 204: HN—O : VAL 
200 
SER 204: HG— N 14: 
NNK 




3 1UA2 CDK7 2 ARG 179: N- - -O7: 
NNK  
ALA 180: N- - -O15: 
NNK 
ARG 136, ASP 136, LEU 
138, LYS 139, THR 175, 
TYR 178, ARG 179, ALA 
180, LEU 183, VAL 194, 
ALA 198. 
4 3BLH CDK9 5 SER115: N- - -O: ALA 
111 
SER115: N- - -O: GLY 
112 
ALA152: N - - - O: LYS 
151 
ALA152: N - - - O 15: 
NNK 
TYR 194: OH- - - OE1: 
GLU 221 
 
ALA 111, LEU 114, SER 
115, LYS 151, ALA 152, 
ALA 153, TYR 194, GLU 
221, ARG 225, SER 226, 
PRO 227. 
5 3G33 CDK4 9 LYS 35: HZ1- - -
ASP158:OD1 
LYS 35: HZ1- - -
ASP158:OD2 
LYS 35: HZ1- - -N 14: 
NNK 
LYS 35: HZ1- - -O 15: 
NNK 
LYS 35: HZ3- - -
ASP158:OD1 
LYS 35: HZ1- - -
ASP158:OD2 
ASN 140: HD21- - -
O:ASP140 
LYS 142: HZ3- - - -N10: 
NNK 
ALA 197: HN - - -O: 
ASN 145 
GLY 57, ALA 16, TYR 17, 
LYS 35, ASP 140, LYS 142, 
GLU 144, ASN 145, LEU 
147, ALA 157, ASP 158. 
 
6 3DDP CDK2 6 LYS 33: NZ- - -OE1: 
GLU 51 
LYS 33: NZ- - -N 14: 
NNK 
LYS 33: NZ- - -O 15: 
NNK 
LEU 83: N- - - O 7: 
NNK 
GLN 85: N- - -O: ILE 
135 
ILE 135: N- - -O: 85 
GLN 
ILE 10, VAL 18, ALA 31, 
LYS 33, VAL 64, PHE 80, 
GLU 81, PHE 82, LEU 83, 
HIS 84, GLN 85, ASP 86, 
LEU 134, ALA 144. 
